Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

36.34
Delayed Data
As of Feb 09
 +0.43 / +1.20%
Today’s Change
33.50
Today|||52-Week Range
126.35
-44.02%
Year-to-Date

Today’s Trading

Previous close35.91
Today’s open34.91
Day’s range33.88 - 39.39
Volume692,332
Average volume (3 months)818,473
Market cap$1.4B
Dividend yield--
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)+43.82%
Earnings growth (this year)-63.55%
Earnings growth (next 5 years)--
Revenue growth (last year)+155.82%
P/E ratioNM
Price/Sales57.71
Price/Book3.14

Competitors

 Today’s
change
Today’s
% change
EXAMExamWorks Group Inc-0.10-0.40%
NEONeogenomics Inc+0.02+0.34%
RDNTRadNet Inc+0.20+4.02%
NVTAInvitae Corp-0.23-3.25%
Data as of 02/09/2016

Financials

Next reporting dateMarch 3, 2016
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$65.4M
Annual profit (last year)-$53.5M
Net profit margin-81.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Senior Vice President-
Finance
Glenn Goddard
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers